Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse

Molecular and Cellular Proteomics

Volumn 12, Issue 5, 2013, Pages 1061-1073

  Rayavarapu, Sree ^a,b   Coley, William ^a,b   Cakir, Erdinc ^a   Jahnke, Vanessa ^a   Takeda, ShiN'Ichi ^c   Aoki, Yoshitsugu ^c   Grodish Dressman, Heather ^a   Jaiswal, Jyoti K ^a,b   Hoffman, Eric P ^a,b   Brown, Kristy J ^a,b   Hathout, Yetrib ^a,b   Nagaraju, Kanneboyina ^a,b,d  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d Murine Drug Testing Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DYSTROPHIN; INTEGRIN; LYSINE; PHOSPHOTRANSFERASE; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CALCIUM HOMEOSTASIS; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; ENERGY METABOLISM; GASTROCNEMIUS MUSCLE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISOTOPE LABELING; MITOCHONDRIAL ENERGY TRANSFER; MOUSE; MUSCLE BIOPSY; MUSCLE DISEASE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STABLE ISOTOPE LABELING IN MAMMAL; WILD TYPE;

ANIMALS; BRAIN; DYSTROPHIN; HUMANS; LIVER; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; ORGAN SPECIFICITY; PROTEOME; PROTEOMICS;

EID: 84877590257     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.023127     Document Type: Article

References (45)

1. Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 90, 3710-3714 (Pubitemid 23111437)
2. Oak, S. A., Zhou, Y. W., and Jarrett, H. W. (2003) Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1. J. Biol. Chem. 278, 39287-39295 (Pubitemid 37248483)
3. Spence, H. J., Chen, Y. J., and Winder, S. J. (2002) Muscular dystrophies, the cytoskeleton and cell adhesion. Bioessays 24, 542-552 (Pubitemid 34629874)
4. Evans, N. P., Misyak, S. A., Robertson, J. L., Bassaganya-Riera, J., and Grange, R. W. (2009) Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am. J. Phys. Med. Rehabil. 88, 502-522
5. Spurney, C. F., Gordish-Dressman, H., Guerron, A. D., Sali, A., Pandey, G. S., Rawat, R., Van Der Meulen, J. H., Cha, H. J., Pistilli, E. E., Partridge, T. A., Hoffman, E. P., and Nagaraju, K. (2009) Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 39, 591-602
6. Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., and Barnard, P. J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580 (Pubitemid 19189735)
7. Araki, E., Nakamura, K., Nakao, K., Kameya, S., Kobayashi, O., Nonaka, I., Kobayashi, T., and Katsuki, M. (1997) Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Biochem. Biophys. Res. Commun. 238, 492-497 (Pubitemid 27464414)
8. Collins, C. A., and Morgan, J. E. (2003) Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int. J. Exp. Pathol. 84, 165-172 (Pubitemid 37378518)
9. Ge, Y., Molloy, M. P., Chamberlain, J. S., and Andrews, P. C. (2003) Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3, 1895-1903 (Pubitemid 37305883)
10. Doran, P., Dowling, P., Donoghue, P., Buffini, M., and Ohlendieck, K. (2006) Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim. Biophys. Acta 1764, 773-785
11. Doran, P., Dowling, P., Lohan, J., McDonnell, K., Poetsch, S., and Ohlendieck, K. (2004) Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur. J. Biochem. 271, 3943-3952 (Pubitemid 39331443)
12. Doran, P., Martin, G., Dowling, P., Jockusch, H., and Ohlendieck, K. (2006) Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6, 4610-4621 (Pubitemid 44336975)
13. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
14. Emadali, A., and Gallagher-Gambarelli, M. (2009) [Quantitative proteomics by SILAC: practicalities and perspectives for an evolving approach]. Med. Sci. (Paris) 25, 835-842
15. Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M., Foster, L. J., and Mann, M. (2003) A proteomics strategy to elucidate functional proteinprotein interactions applied to EGF signaling. Nat. Biotechnol. 21, 315-318 (Pubitemid 36314817)
16. Kruger, M., Kratchmarova, I., Blagoev, B., Tseng, Y. H., Kahn, C. R., and Mann, M. (2008) Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. U.S.A. 105, 2451-2456 (Pubitemid 351520534)
17. Amanchy, R., Kalume, D. E., Iwahori, A., Zhong, J., and Pandey, A. (2005) Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 4, 1661-1671 (Pubitemid 41464793)
18. Kruger, M., Moser, M., Ussar, S., Thievessen, I., Luber, C. A., Forner, F., Schmidt, S., Zanivan, S., Fassler, R., and Mann, M. (2008) SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 134, 353-364 (Pubitemid 352010327)
19. McClatchy, D. B., Liao, L., Park, S. K., Xu, T., Lu, B., and Yates, J. R., III (2011) Differential proteomic analysis of mammalian tissues using SILAM. PLoS One 6, e16039
20. McClatchy, D. B., and Yates, J. R., 3rd (2008). Stable isotope labeling of mammals (SILAM). CSH Protoc. 2008, pdb.prot4940
21. Lu, X. M., Tompkins, R. G., and Fischman, A. J. (2012) SILAM for quantitative proteomics of liver Akt1/PKBalpha after burn injury. Int. J. Mol. Med. 29, 461-471
22. Huang, T. C., Sahasrabuddhe, N. A., Kim, M. S., Getnet, D., Yang, Y., Peterson, J. M., Ghosh, B., Chaerkady, R., Leach, S. D., Marchionni, L., Wong, G. W., and Pandey, A. (2012) Regulation of lipid metabolism by dicer revealed through SILAC mice. J. Proteome Res. 11, 2193-2205
23. Zanivan, S., Krueger, M., and Mann, M. (2012) In vivo quantitative proteomics: the SILAC mouse. Methods Mol. Biol. 757, 435-450
24. Monetti, M., Nagaraj, N., Sharma, K., and Mann, M. (2011) Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat. Methods 8, 655-658
25. Geiger, T., Wisniewski, J. R., Cox, J., Zanivan, S., Kruger, M., Ishihama, Y., and Mann, M. (2011) Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protoc. 6, 147-157
26. Jahnke, V. E., Sabido, O., Defour, A., Castells, J., Lefai, E., Roussel, D., and Freyssenet, D. (2010) Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells. PLoS One 5, e8637
27. Larance, M., Bailly, A. P., Pourkarimi, E., Hay, R. T., Buchanan, G., Coulthurst, S., Xirodimas, D. P., Gartner, A., and Lamond, A. I. (2011) Stableisotope labeling with amino acids in nematodes. Nat. Methods. 8, 849-851
28. Sury, M. D., Chen, J. X., and Selbach, M. (2010) The SILAC fly allows for accurate protein quantification in vivo. Mol. Cell. Proteomics 9, 2173-2183
29. Hojlund, K., Yi, Z., Hwang, H., Bowen, B., Lefort, N., Flynn, C. R., Langlais, P., Weintraub, S. T., and Mandarino, L. J. (2008) Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol. Cell. Proteomics 7, 257-267 (Pubitemid 351298440)
30. Gelfi, C., Vasso, M., and Cerretelli, P. (2011) Diversity of human skeletal muscle in health and disease: contribution of proteomics. J. Proteomics 74, 774-795
31. Drexler, H. C., Ruhs, A., Konzer, A., Mendler, L., Bruckskotten, M., Looso, M., Gunther, S., Boettger, T., Kruger, M., and Braun, T. (2012). On marathons and sprints: an integrated quantitative proteomics and transcriptomics analysis of differences between slow and fast muscle fibers. Mol. Cell. Proteomics 11, M111.010801
32. Ohlendieck, K. (2011) Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques. Skelet. Muscle 1, 6
33. Carberry, S., Zweyer, M., Swandulla, D., and Ohlendieck, K. (2012) Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy. Int. J. Mol. Med. 30, 229-234
34. Doran, P., Wilton, S. D., Fletcher, S., and Ohlendieck, K. (2009) Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 9, 671-685
35. Lewis, C., Doran, P., and Ohlendieck, K. (2012) Proteomic analysis of dystrophic muscle. Methods Mol. Biol. 798, 357-369
36. Lewis, C., and Ohlendieck, K. (2010) Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem. Biophys. Res. Commun. 396, 1024-1029
37. Alagaratnam, S., Mertens, B. J., Dalebout, J. C., Deelder, A. M., van Ommen, G. J., den Dunnen, J. T., and Hoen, P. A. (2008). Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 8, 1552-1563 (Pubitemid 351580202)
38. Wang, H. V., Chang, L. W., Brixius, K., Wickstrom, S. A., Montanez, E., Thievessen, I., Schwander, M., Muller, U., Bloch, W., Mayer, U., and Fassler, R. (2008) Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage. J. Cell Biol. 180, 1037-1049 (Pubitemid 351398427)
39. Gheyara, A. L., Vallejo-Illarramendi, A., Zang, K., Mei, L., St-Arnaud, R., Dedhar, S., and Reichardt, L. F. (2007) Deletion of integrin-linked kinase from skeletal muscles of mice resembles muscular dystrophy due to alpha 7 beta 1-integrin deficiency. Am. J. Pathol. 171, 1966-1977
40. Liu, J., Milner, D. J., Boppart, M. D., Ross, R. S., and Kaufman, S.J. (2012) beta1D chain increases alpha7beta1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum. Mol. Genet. 21, 1592-1603
41. Robert, V., Massimino, M. L., Tosello, V., Marsault, R., Cantini, M., Sorrentino, V., and Pozzan, T. (2001) Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 276, 4647-4651
42. Lucas-Heron, B., Schmitt, N., and Ollivier, B. (1990) Muscular dystrophy: possible role of mitochondrial deficiency in muscle degeneration processes. J. Neurol. Sci. 95, 327-334 (Pubitemid 20097719)
43. Hopf, F. W., Turner, P. R., and Steinhardt, R. A. (2007) Calcium misregulation and the pathogenesis of muscular dystrophy. Subcell. Biochem. 45, 429-464
44. Whitehead, N. P., Yeung, E. W., and Allen, D. G. (2006) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol. 33, 657-662 (Pubitemid 43894030)
45. Jahnke, V. E., Van Der Meulen, J. H., Johnston, H. K., Ghimbovschi, S., Partridge, T., Hoffman, E. P., and Nagaraju, K. (2012) Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2, 16